Lakeshore Acquisition I Corp.

Lakeshore Acquisition I Corp.

LAAAW
Lakeshore Acquisition I Corp.US flagNASDAQ Capital Market
0.15
USD
+0.02
- -
Lakeshore Acquisition I Corp.
LAAAW
(NASDAQ Capital Market)

Recent

price

0.15

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
Lakeshore Acquisition I Corp. (LAAAW) operates as a blank check company, or special purpose acquisition company (SPAC), whose sole purpose is to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities; it conducts no significant operations prior to completing such a transaction. Incorporated in 2021 as a Cayman Islands exempted company and headquartered in Shanghai, China, with certain references to New York, NY operations, the company raised $50 million in its initial public offering in June 2021 through 5 million units at $10 each, consisting of one ordinary share and three-quarters of one redeemable warrant each exercisable at $11.50 per whole share; the warrants trade separately under the LAAAW ticker on Nasdaq Capital Market. In December 2022, Lakeshore completed its business combination with ProSomnus Sleep Technologies, Inc., a developer of precision-custom intraoral medical devices for treating obstructive sleep apnea; post-merger, the combined entity operates as ProSomnus, Inc. (Nasdaq: OSA), with Lakeshore's ordinary shares and units delisted and suspended from trading, while LAAAW warrants persist as legacy securities exercisable into ProSomnus common stock upon meeting post-combination conditions. The transaction, initially announced in May 2022 for an enterprise value of approximately $168 million including debt assumption and backed by $30 million in convertible notes from Cohanzick Management and CrossingBridge Advisors, received shareholder approval on December 2, 2022, following a three-month extension secured in September 2022; no subsequent major changes, new funding, or further combinations involving Lakeshore or LAAAW have been reported as of late 2025.